Expert perspectives on the design and communication of endpoints in Alzheimer's disease clinical trials
- DOI
- 10.1002/alz.71951
- Published
- 2026-10
- Container
- Alzheimer's & Dementia
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/alz.71951,
title = {Expert perspectives on the design and communication of endpoints in Alzheimer's disease clinical trials},
author = {Pierre N. Tariot and Samuel P. Dickson and John Dwyer and Carlos Granda and Lynne Hughes and Jason Karlawish and Nicklas Linz and Kavita V. Nair and Russ Paulsen and Daniel Pawson and Robert Perneczky and Suzanne E. Schindler and Emily Scholler and James Taylor and Benjamin Tiede and George Vradenburg},
year = {2026},
journal = {Alzheimer's \& Dementia},
doi = {10.1002/alz.71951},
url = {https://doi.org/10.1002/alz.71951}
}RIS
TY - JOUR TI - Expert perspectives on the design and communication of endpoints in Alzheimer's disease clinical trials AU - Pierre N. Tariot AU - Samuel P. Dickson AU - John Dwyer AU - Carlos Granda AU - Lynne Hughes AU - Jason Karlawish AU - Nicklas Linz AU - Kavita V. Nair AU - Russ Paulsen AU - Daniel Pawson AU - Robert Perneczky AU - Suzanne E. Schindler AU - Emily Scholler AU - James Taylor AU - Benjamin Tiede AU - George Vradenburg PY - 2026 JO - Alzheimer's & Dementia DO - 10.1002/alz.71951 UR - https://doi.org/10.1002/alz.71951 ER -
APA
Tariot, P. N., Dickson, S. P., Dwyer, J., Granda, C., Hughes, L., Karlawish, J., Linz, N., Nair, K. V., Paulsen, R., Pawson, D., Perneczky, R., Schindler, S. E., Scholler, E., Taylor, J., Tiede, B., & Vradenburg, G. (2026). Expert perspectives on the design and communication of endpoints in Alzheimer's disease clinical trials. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71951
Source records
- crossref · retrieved 2026-11-03T19:58:29.432Z